The EHA Research Roadmap: Malignant Myeloid Diseases

Affiliations

• ¹ Department of Internal Medicine III, Ulm University Hospital, Germany.
• ² Department of Molecular Medicine, University of Pavia & Department of Hematology Oncology, IRCCS S. Matteo Hospital Foundation, Pavia, Italy.
• ³ Amsterdam UMC, Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
• ⁴ Universitätsklinikum Jena, Klinik für Innere Medizin II, Hämatologie/Onkologie, Jena, Germany.
• ⁵ Center Research and Innovation of Myeloproliferative neoplasms, CRIMM, University of Florence, Azienda Ospedaliera-universitaria Careggi, Italy.
• ⁶ Department of Hematology, Oncology, and Tumor Immunology, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Germany.
• ⁷ Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.
• ⁸ Hospital Clínic Barcelona, Spain.
• ⁹ Centre For Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.
• ¹⁰ Institut de Recherche Saint-Louis (IRSL), Université de Paris, Hôpital Saint-Louis, Paris, France.
• ¹¹ Département (DMU) d'hématologie et immunologie, Assistance Publique Hôpitaux de Paris, Hôpital St Louis, Université de Paris, France.
• ¹² Leukemia Patient Advocates Foundation, Bern, Switzerland.
• ¹³ Klinik für Hämatologie, Onkologie und Klinische Immunologie, Universitätsklinikum Düsseldorf, Heinrich-Heine Universität Düsseldorf, Germany.
• ¹⁴ University of Poitiers, France.
• ¹⁵ Department of Haematology, Guys and St Thomas'Hospital, London, United Kingdom.
• ¹⁶ Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
• ¹⁷ University of Insubria, Varese, Italy.
• ¹⁸ Hospital de la Santa Creu i de Sant Pau and Jose Carreras Leukemia Research Institute, Barcelona, Spain.
• ¹⁹ Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland.
• ²⁰ Multi-specialized Center of Oncology and Traumatology, Lodz, Poland.